Zimmer Biomet Holdings (NYSE:ZBH) Q3 results:
Sales: $1,892.4M (+3.0%); Knees: $651.9M (+3.8%); Hips: $460.2M (+3.5%); S.E.T.: $437.7M (+5.6%); Spine & CMF: $181.3M (-2.0%).
Net income: $431.1M (+165.8%); EPS: $2.08 (+163.3%).
Cash flow ops: $577.9M (+19.4%).
2019 guidance unchanged.
Shares up 4% premarket on light volume.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.